Moscow Laboratory Group Gemotest Expands Cooperation with iSOFT

iSOFT Group LimitediSOFT Group Limited announces - The Gemotest group, one of the five biggest providers of laboratory diagnostic services in Moscow, expands its central laboratory network by integrating the iSOFT Laboratory Module for microbiology. After the successful implementation of the iSOFT laboratory information system in 2008 the diagnostics provider now wants to further expand its service profile in order to continue the set growth strategy in the future. The further development of the cooperation enables iSOFT to step forward into the Russian healthcare market and successfully widen its footprint in Eastern Europe.

Within this new project Gemotest will install the new iSOFT Laboratory microbiology module in the overarching network in its central laboratory in Moscow. In combination with the existing iSOFT Laboratory components the results of microbiological analysis will be integrated reliably into the workflow. This enables Gemotest to extend its services for special laboratory diagnostic examinations. Moreover, the high flexibility and scalability of the entire laboratory system allows for the implementation of additional 10 analytical devices into the IT environment of the laboratory group as well as the smooth set up of further working stations.

By this diversification Gemotest intends to increase its competitive position and win further market shares in the field of special laboratory diagnostic examinations. This aspect is an essential building block for the growth plans of the Russian diagnostics service provider.

"With Gemotest we found a partner in the Russian market, who already successfully implements modern IT systems for the management of workflow processes," said Peter Herrmann, Managing Director, iSOFT Health. "The Russian healthcare market with a total volume of approximately two billion U.S. Dollars and constant growth rates in the last few years is a key market for iSOFT. That's why it is particularly important to have strong regional partners and reference sites, who can serve as "Proof of Concept" for further potential customers."

The order allows Gemotest the implementation of a comprehensive laboratory infrastructure, which provides the necessary scalability to integrate additional devices and locations into the existing IT environment. To take advantage of this flexibility and scalability, Gemotest invested a total of approximately €100.000 in the expansion of the laboratory IT system as well as for support and system maintenance over five years.

Related news articles:

About Gemotest
The Moscow-based laboratory group Gemotest has entrusted more than 100 employees with the provision of diagnostic services. Every day up to 11,000 samples are analyzed and processed. The company, which for years pursued clear growth strategy, plans in the next years to establish other laboratory facilities in Russia and is one of the fastest-growing laboratory service providers in the country.

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 locations worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...